4.4 Article

Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens

Journal

CANCER CYTOPATHOLOGY
Volume 130, Issue 7, Pages 523-530

Publisher

WILEY
DOI: 10.1002/cncy.22563

Keywords

Cobas HPV assay; fine-needle aspiration (FNA) needle rinse; head and neck fine-needle aspiration (FNA); human papillomavirus; human papillomavirus 16 (HPV-16); oropharyngeal squamous cell carcinoma

Funding

  1. Department of Pathology of The University of Texas MD Anderson Cancer Center
  2. National Institutes of Health [R01CA236859]

Ask authors/readers for more resources

This study evaluated the accuracy of the Cobas human papillomavirus (HPV) assay for detecting high-risk HPV and HPV-16 in head and neck fine-needle aspiration (FNA) specimens with squamous cell carcinoma. The results showed that the Cobas HPV assay had high accuracy in determining HPV status in FNA specimens and that FNA needle rinse was valid for Cobas HPV testing.
Background This study evaluated the detection accuracy of the Cobas human papillomavirus (HPV) assay for high-risk human papillomavirus (hrHPV) and HPV-16 in head and neck fine-needle aspiration (FNA) specimens with squamous cell carcinoma. Methods Head and neck FNA biopsy specimens from 2012 to 2020 were retrospectively collected. Cobas HPV testing was performed on 90 FNA specimens with valid Cervista HPV testing results. Results of Cobas HPV and Cervista HPV assays were compared. A Linear Array or SPF10-LiPA25 HPV genotyping assay resolved cases with discrepant results. The kappa value and accuracy of Cobas HPV testing were calculated. The accuracy of the Cobas HPV assay was also determined in 42 FNA needle-rinse specimens. Results Cobas HPV was positive in 82% of the FNA specimens (74 of 90). The concordance between Cobas HPV and Cervista HPV test results was 88.9% (80 of 90) with substantial agreement (kappa = 0.669; 95% CI, 0.481-0.856). With HPV genotyping confirmation in cases with discrepant results between the 2 HPV assays, Cobas HPV showed 100% sensitivity and specificity for hrHPV. HPV-16 was detected in 88% of HPV-positive cases (65 of 74). HPV genotyping confirmed 1 false-negative HPV-16 result and 1 false-positive HPV-16 result. Overall, the accuracy of Cobas HPV for HPV-16 was 97.8%. The accuracy of Cobas HPV in FNA needle-rinse specimens was 100%. Conclusions The Cobas HPV assay is highly accurate for determining the HPV status in head and neck FNA specimens. FNA needle rinse is valid for Cobas HPV testing in patients with squamous cell carcinoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available